Showing results (371-380 of 569) with videos related to
Sort By:
Pageof 57
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group]H Akaza, J Shimazaki, K Tashiro, et al.Neuroscience Letters|August 6, 1993
Identification of androgen receptor in the rat spinal motoneurons. Immunohistochemical and immunoblotting analyses with monoclonal antibodyT Matsuura, A Ogata, T Demura, et al.The Biochemical Journal|August 15, 1994
A synthetic peptide deduced from the sequence in the cross-region of laminin A chain mediates neurite outgrowth, cell attachment and heparin bindingK Tashiro, I Nagata, N Yamashita, et al.Neurology|July 13, 2000
Deep brain stimulation of subthalamic area for severe proximal tremorM Kitagawa, J Murata, S Kikuchi, et al.Journal of Neurology|April 29, 2000
Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 alleleT Fukazawa, S Kikuchi, H Sasaki, et al.Journal of Neurology|October 20, 1999
Mosaicism of unstable CAG repeats in the brain of spinocerebellar ataxia type 2T Matsuura, H Sasaki, I Yabe, et al.Hinyokika Kiyo. Acta Urologica Japonica|September 29, 1999
[Percutaneous resection of renal pelvic fibroepithelial polyp with medullary sponge kidney: a case report]K Tashiro, S Iwamuro, T Hatano, et al.Acta Neuropathologica|January 29, 2000
Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement of glycation in motoneuron diseasesS Kikuchi, A Ogata, K Shinpo, et al.The Biochemical Journal|May 7, 1999
An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycanK Tashiro, A Monji, I Yoshida, et al.European Neurology|January 1, 1997
Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-upN Ogawa, I Kanazawa, H Kowa, et al.Pageof 57